• Explore /
  • Poster
  • / Association of primary prophylactic (PP) granulocyte-colony stimulating factor (G-CSF) use with chemotherapy dose modifications and relative dose intensity (RDI) among breast cancer patients receiving high-risk regimens for febrile neutropenia (FN).

Association of primary prophylactic (PP) granulocyte-colony stimulating factor (G-CSF) use with chemotherapy dose modifications and relative dose intensity (RDI) among breast cancer patients receiving high-risk regimens for febrile neutropenia (FN).

Abstract Poster

Authors

null

Jaime Shaw

Amgen, San Diego, CA

Jaime Shaw, Jennifer Schenfeld, Akhila Balasubramanian, Renee Jaramillo, Darcie Sandschafer, Michael Anthony Kelsh, Reshma L. Mahtani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care

Track

Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities

Sub Track

Real-World Evidence

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 314)

DOI

10.1200/JCO.2020.39.28_suppl.314

Abstract #

314

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: A. Soni

First Author: Douglas W. Blayney

First Author: Roopa Lakhanpal

First Author: Katherine Lovat